CLASS II ONGOING Device recall · Reported 8 Apr 2026 · FDA Enforcement Report

Burlington Medical, Caps recalled

Burlington Medical is recalling Burlington Medical, Caps, distributed nationwide in the US. The recall was initiated on 11 Feb 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll serial numbers are affected that were manufactured with Xenolite 800 attenuation material from 01/16/2025 to 01/21/2026. 1. Model Number: R8CAP; UDI-DI (Product Code): 00840331272185 (CAP8-R8CAP-LG_XL), 00840331272178 (CAP8-R8CAP-SM_MD). 2. Model Number: S8CAP; UDI-DI (Product Code): 00840331272208 (CAP8-S8CAP-LG_XL), 00840331272192 (CAP8-S8CAP-SM_MD). 3.Model Number: U8CAP; UDI-DI (Product Code): 00840331272222 (CAP8-U8CAP-LG_XL), 00840331272215 (CAP8-U8CAP-SM_MD).

Quantity recalled961 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number: Z-1760-2026
FDA event ID: 98415
Recalling firm: Burlington Medical, Newport News, VA
Classification: Class II
Status: Ongoing
Recall initiated: 11 Feb 2026
FDA classified: 2 Apr 2026
Reported: 8 Apr 2026
Type: Voluntary: Firm initiated
Customers notified by: Letter
Reason category: Potency & Assay
Device type: Other Medical Devices

Timeline

11 Feb 2026	Recall initiated by company
2 Apr 2026	Classified by FDA	+50 days
8 Apr 2026	Published in enforcement report	+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Potential for attenuation degradation over time, decreasing the lifespan.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Burlington Medical, Caps.

Where it was distributed

Worldwide distribution. Nationwide distribution in the US and international distribution to Canada, Australia, Bangladesh, Chile, Hong Kong, India, Mexico, Malaysia, Panama, Singapore, Thailand, Taiwan, Uruguay, and Vietnam.

Nationwide

Questions about this recall

Is Burlington Medical, Caps recalled?

Yes. Burlington Medical recalled Burlington Medical, Caps on 11 Feb 2026. The recall is Class II and its status is Ongoing. Recall number Z-1760-2026.

Why was it recalled?

Potential for attenuation degradation over time, decreasing the lifespan.

Which lots are affected?

All serial numbers are affected that were manufactured with Xenolite 800 attenuation material from 01/16/2025 to 01/21/2026. 1. Model Number: R8CAP; UDI-DI (Product Code): 00840331272185 (CAP8-R8CAP-LG_XL), 00840331272178 (CAP8-R8CAP-SM_MD). 2. Model Number: S8CAP; UDI-DI (Product Code): 00840331272208 (CAP8-S8CAP-LG_XL), 00840331272192 (CAP8-S8CAP-SM_MD). 3.Model Number: U8CAP; UDI-DI (Product Code): 00840331272222 (CAP8-U8CAP-LG_XL), 00840331272215 (CAP8-U8CAP-SM_MD).

Where was it sold?

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Burlington Medical

All 37

Reported	Class	Recall	Company	Reason	Where
8 Apr 2026Device	CLASS II	BAT (Breast, Axilla and Thyroid) Coverage recalled by Burlington Medical	Burlington Medical	Potency & Assay	Nationwide
8 Apr 2026Device	CLASS II	Burlington Medical, Kilt recalled	Burlington Medical	Potency & Assay	Nationwide
8 Apr 2026Device	CLASS II	Thyroid Shield recalled by Burlington Medical	Burlington Medical	Potency & Assay	Nationwide
8 Apr 2026Device	CLASS II	Burlington Medical, Blockers recalled	Burlington Medical	Potency & Assay	Nationwide
8 Apr 2026Device	CLASS II	Frontal Aprons recalled by Burlington Medical	Burlington Medical	Potency & Assay	Nationwide

Other Other Medical Devices recalls

All 13,778

Reported	Class	Recall	Company	Reason	Where
16 Sep 2026Device	CLASS II	Citric Complete Dry Citric Acid Concentrate recalled	Nipro Renal Soultions USA	Other	Nationwide
16 Sep 2026Device	CLASS I	Kit: Epidural/Pain TQC 20/Cs recalled by Medical Action Industries	Medical Action Industries Inc. 306	Sterility	6 states
16 Sep 2026Device	CLASS II	Halyard IV Start Kit Non-Sterile recalled by Avid Medical	Avid Medical	Sterility	Nationwide
16 Sep 2026Device	CLASS I	Kit: Single Shot Epidural 20/Cs recalled by Medical Action Industries	Medical Action Industries Inc. 306	Sterility	6 states
16 Sep 2026Device	CLASS II	AMS Convenience Kit: Dsaek Pack - RX recalled	Windstone Medical Packaging	Device Malfunction	Nationwide